Inceptionr LLC Trims Stock Position in Tenet Healthcare Corporation $THC

Inceptionr LLC lessened its holdings in Tenet Healthcare Corporation (NYSE:THC) by 49.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,208 shares of the company’s stock after selling 3,134 shares during the period. Inceptionr LLC’s holdings in Tenet Healthcare were worth $651,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Crestwood Advisors Group LLC grew its holdings in shares of Tenet Healthcare by 2.5% in the third quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock valued at $529,000 after purchasing an additional 64 shares during the period. ProShare Advisors LLC raised its stake in shares of Tenet Healthcare by 1.7% in the second quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock valued at $725,000 after acquiring an additional 67 shares in the last quarter. Quadcap Wealth Management LLC increased its stake in shares of Tenet Healthcare by 1.7% during the second quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock worth $721,000 after buying an additional 69 shares during the period. Andina Capital Management LLC raised its holdings in shares of Tenet Healthcare by 2.1% in the 3rd quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock valued at $682,000 after purchasing an additional 69 shares in the last quarter. Finally, Choreo LLC boosted its holdings in Tenet Healthcare by 2.9% in the third quarter. Choreo LLC now owns 2,636 shares of the company’s stock valued at $535,000 after purchasing an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of THC opened at $237.30 on Wednesday. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $247.21. The stock has a market capitalization of $20.64 billion, a P/E ratio of 15.32, a P/E/G ratio of 1.19 and a beta of 1.39. The firm’s 50 day moving average is $211.66 and its 200-day moving average is $203.29. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm’s revenue was up 8.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Insider Buying and Selling

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 8,000 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the transaction, the executive vice president owned 12 shares in the company, valued at $2,866.20. This trade represents a 99.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 42,195 shares of company stock worth $9,823,406. Corporate insiders own 0.81% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on THC shares. Barclays lifted their price target on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. Finally, Truist Financial increased their price target on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $247.67.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.